Cancer Institute– A national cancer institute
designated cancer center

Conditions We Treat

The following is a list of diseases treated by the Stanford Blood and Marrow Transplant Program.

Acute Leukemia
Acute Myelogenous Leukemia
Disease Status:
  • First, second or subsequent remission
  • Induction failure
  • Relapse
 Transplant Type:
Acute Lymphoblastic Leukemia
Disease Status:
  • First, second or subsequent remission
  • Induction failure
  • Relapse
 Transplant Type:

Chronic Leukemia
Chronic Myelogenous Leukemia
Disease Status:
  • Chronic, accelerated or blast phase
 Transplant Type:
Chronic Lymphocytic Leukemia
Disease Status:
  • High Risk Disease
  • Relapse
 Transplant Type:

Lymphoma
Hodgkin's Disease
Disease Status:
  • First or subsequent relapse
  • Second or subsequent remission
  • Failure to achieve a complete response
 Transplant Type:
Non-Hodgkin's Lymphoma
Disease Status:
  • First or subsequent relapse
  • First remission with high risk disease
  • Second or subsequent remission
  • Failure to achieve a complete response
 Transplant Type:

Plasma Cell Dyscrasias
Multiple Myeloma
Disease Status:
  • Stage I (select diseases)
  • Stage II or III
  • First or subsequent relapse
 Transplant Type:
Amyloidosis
  Transplant Type:
Waldenstrom's Macroglobulinemia
  Transplant Type:

Other Hematologic Diseases
Aplastic Anemia
  Transplant Type:
Myelodysplastic Syndrome
  Transplant Type:
Myeloproliferative Diseases
  Transplant Type:
Paroxysmal Nocturnal Hemoglobinuria
  Transplant Type:
 
Germ Cell
Disease Status:
  • Advanced Disease/Relapse
 Transplant Type:
Sarcoma
Disease Status:
  • Advanced Disease
 Transplant Type:

Autoimmune Disorders
Lupus
Disease Status:
  • Life-threatening lupus refractory to standard therapies
 Transplant Type:

 

Stanford Medicine Resources:

Footer Links: